Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
microbial extract
- Development stage
- Unknown
- Lead developer
- Uute Scientific
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Topical
01
Overview
Microbial extract is a topical microbial therapy derived from composted agricultural stack, gardening soils, deciduous leaf litter, peat, and Sphagnum moss. It is being investigated for its potential to treat atopic dermatitis by enhancing immune tolerance and mitigating eczema symptoms. The extract works by down-regulating pro-inflammatory cytokines such as IL-1β, IL-22, and IL-33, and the antimicrobial peptide human β-defensin 2.
- Brand names
- Re-Connecting Nature
- Other names
- RCNRe-Connecting Nature extractRe-Connecting Nature microbe extract
02
Targets
DEFB4A (Human β-defensin-2)IL1B (Interleukin-1 beta)IL22 (Interleukin 22)IL33 (IL-33)
Beyond the preview
Go deeper on microbial extract.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on microbial extract.